Treatment of herpesvirus associated primary effusion lymphoma with intracavity cidofovir.
about
Targeting KSHV/HHV-8 latency with COX-2 selective inhibitor nimesulide: a potential chemotherapeutic modality for primary effusion lymphomaCurrent and potential treatments for ubiquitous but neglected herpesvirus infectionsβ-HHVs and HHV-8 in Lymphoproliferative Disorders.An unusual case of Primary Effusion Lymphoma with aberrant T-cell phenotype in a HIV-negative, HBV-positive, cirrhotic patient, and review of the literature.Comparison of human herpes virus 8 related primary effusion lymphoma with human herpes virus 8 unrelated primary effusion lymphoma-like lymphoma on the basis of HIV: report of 2 cases and review of 212 cases in the literature.Primary effusion lymphoma diagnosed by pericardiocentesis.New approaches to the treatment of human herpesvirus 8-associated disease.Use of cidofovir for the treatment of HIV-negative human herpes virus-8-associated primary effusion lymphoma.Therapeutic options for HIV-associated lymphomas.Primary effusion lymphoma in an elderly patient effectively treated by lenalidomide: case report and review of literature.Current status of treatment for primary effusion lymphoma.Primary effusion lymphoma in the absence of HIV infection--clinical presentation and management.KSHV targeted therapy: an update on inhibitors of viral lytic replication.Clinical management of HIV-associated hematologic malignancies.STAT3 Regulates Lytic Activation of Kaposi's Sarcoma-Associated Herpesvirus.Concurrent targeting of eicosanoid receptor 1/eicosanoid receptor 4 receptors and COX-2 induces synergistic apoptosis in Kaposi's sarcoma-associated herpesvirus and Epstein-Barr virus associated non-Hodgkin lymphoma cell lines.Human Herpesvirus 8-Related Primary Effusion Lymphoma After Liver Transplantation.Head and Neck Lymphomas in HIV Patients: a Clinical Perspective.Reversal of the glycolytic phenotype of primary effusion lymphoma cells by combined targeting of cellular metabolism and PI3K/Akt/ mTOR signaling.Primary effusion lymphoma involving three body cavitiesSustained complete remission of primary effusion lymphoma with adjunctive ganciclovir treatment in an HIV-positive patientAntineoplastic effects of liposomal short interfering RNA treatment targeting BLIMP1/PRDM1 in primary effusion lymphoma.Kaposi's sarcoma herpesvirus lytic replication compromises apoptotic response to p53 reactivation in virus-induced lymphomas.Disease remission in a horse with EHV-5-associated lymphoma.Bortezomib (PS-341) in patients with human herpesvirus 8-associated primary effusion lymphoma.Survival of patients with CD20-negative variants of large B-cell lymphoma: an analysis of the National Cancer Data Base.Case report of a primary effusion lymphoma successfully treated with oral valganciclovir after failing chemotherapy.Primary effusion lymphoma: current perspectives.FUS Negatively Regulates Kaposi's Sarcoma-Associated Herpesvirus Gene Expression
P2860
Q21135231-08526460-E0F9-4526-B016-1D53775A47B6Q27023452-64CCCE63-C98D-4939-B577-BD72CF55DB4CQ35560251-D0B7DE82-2F9D-4ACC-821A-C97959597B1EQ36180568-C38891E2-8230-46B1-A412-2905E8A1A651Q36668747-2A0C8B23-1B7D-4242-BF6A-8E54F8068FAEQ37061042-C0386759-A781-4372-B7A3-7A95ED1BE765Q37211987-D14DA84E-D79C-4058-B228-046B438F597CQ37765465-A95C39EC-88E8-4298-B53D-547D01202332Q37781368-A1701E02-E1DA-4CC5-BBCA-79357C54F23EQ38194434-0094647A-5970-4B66-863B-A03D6943B83EQ38264454-C5DEEAF7-4EA4-447E-B713-F76CD0FBA399Q38270091-45F76F6E-1BDB-40D4-A6B4-386DBD4D554EQ38271135-5A397068-8499-4ACB-B43C-9294F4A1889BQ38664912-DE3B8B25-849F-41C3-995F-F29DB14E623BQ38838049-9FC95594-A9D3-4083-910F-DF0A9AA75071Q39176686-1FB43DB5-A09E-42C9-A5CD-4B5FC76F474BQ41219712-2A03526C-9C7F-47C6-BB95-58FE2512CF93Q41919568-6EDA6A5A-BB9B-445E-91EA-E019DD7542DEQ42026999-15129F5B-04D0-4360-B52A-78DFB535AC38Q42087566-B6C6220D-8649-40B1-BC21-4A158BBE6122Q42176771-EACFEA5A-0B97-40F9-BB83-8ABE0F27A947Q42910824-B19F2AB9-44DB-4473-8E21-08BB8D18703FQ45358610-0A05EBA7-073F-4ABC-A763-0FC02F8A0E3DQ46111900-ADDD6EBA-3449-4D2B-997F-AD58E07C0279Q46701461-6FDF63CF-5476-475B-AA4A-6DECF4144D3AQ47821848-F66EDFFF-144C-499C-9BD8-F7A4A76C7E34Q48330061-67D283D0-6A05-4A0A-A7C4-5A97149405E2Q55518093-42B4C7A8-F1DC-4672-ABC7-C78E6B8E4089Q57029061-FF956624-49D9-432A-B9AA-5F533F42E932
P2860
Treatment of herpesvirus associated primary effusion lymphoma with intracavity cidofovir.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Treatment of herpesvirus associated primary effusion lymphoma with intracavity cidofovir.
@en
Treatment of herpesvirus associated primary effusion lymphoma with intracavity cidofovir.
@nl
type
label
Treatment of herpesvirus associated primary effusion lymphoma with intracavity cidofovir.
@en
Treatment of herpesvirus associated primary effusion lymphoma with intracavity cidofovir.
@nl
prefLabel
Treatment of herpesvirus associated primary effusion lymphoma with intracavity cidofovir.
@en
Treatment of herpesvirus associated primary effusion lymphoma with intracavity cidofovir.
@nl
P2093
P2860
P50
P356
P1433
P1476
Treatment of herpesvirus associated primary effusion lymphoma with intracavity cidofovir
@en
P2093
L Ravazzini
M Morselli
R Roncaglia
P2860
P2888
P304
P356
10.1038/SJ.LEU.2403646
P577
2005-03-01T00:00:00Z
P5875
P6179
1003082170